A scientist who studies how dopamine works in the brain will use a $400,000 grant to investigate clues that the chemical may have a role in Alzheimer’s disease. The information could be used to shut down the degenerative process at the beginning, before patients lose brain cells and memory they will never get back. “All therapeutic treatments (for Alzheimer’s) are symptomatic. They can’t slow down the disease,” said Michael Beckstead, who works in the Aging & Metabolism Research Program at the Oklahoma Medical Research Foundation. “Once brain cells are dead, they can’t come back,” Beckstead said. “If we catch it early on before the cells really start dying off, we could develop therapies to arrest the process in its earliest stages before any cognitive damage is done.” That will require a way to diagnose Alzheimer’s sooner because it usually isn’t diagnosed until memory loss has set in. Some of the earliest symptoms are depression and apathy, which involve areas of the brain Beckstead studies. “People with depression and apathy are much more likely to develop Alzheimer’s later in life,” he said. With the new grant from the National Institute on Aging, he will be studying dopamine neurons in the brains… Read full this story
- Researchers Seek Sage Advice Of Elders On Aging Issues
- In Effort To Stop Legionnaires Disease, City Health Inspectors Bungle Thousands of Cooling Tower Inspections
- Call for Applications! TDR Clinical Research and Development Fellowships
- Appalachian health researchers discuss work (much of it about drugs) and are urged to engage more closely with communities
- Appalachian health researchers discuss work, with three sessions on drugs, and are urged to engage more closely with communities
- New online implementation research training launched by TDR
- Tickborne Diseases Hit Record Levels In U.S.
- Snapchat Files All-Caps DMCA Takedown After the Source Code It Leaked Hit Github
- Taycan Fast Charging Station Gets a Name: Porsche Pit Stop
- Equitable partnerships for tackling killer infectious diseases
Researcher seeks to stop Alzeheimer's disease at its source have 339 words, post on oklahoman.com at July 14, 2019. This is cached page on USA Breaking News. If you want remove this page, please contact us.